Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EPS (Weighted Average and Diluted) (2020 - 2025)

Core Scientific's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at $0.6 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 5.26% year-over-year to $0.6; the TTM value through Dec 2025 reached $1.35, up 127.72%, while the annual FY2025 figure was -$0.88, 81.93% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.6 at Core Scientific, up from -$0.46 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.25 in Q1 2025 and bottomed at -$5.05 in Q2 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.06 (2021), against an average of -$0.51.
  • The largest annual shift saw EPS (Weighted Average and Diluted) surged 378950.96% in 2021 before it tumbled 16733.33% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.25 in 2021, then crashed by 524.0% to -$1.06 in 2022, then soared by 51.89% to -$0.51 in 2023, then skyrocketed by 211.76% to $0.57 in 2024, then grew by 5.26% to $0.6 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's EPS (Weighted Average and Diluted) are $0.6 (Q4 2025), -$0.46 (Q3 2025), and -$0.04 (Q2 2025).